«Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis». One Health & Risk Management 6, no. 3 (сентябрь 6, 2025): 44–53. просмотрено июль 24, 2026. https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/827.